The correlations between the expression of TDO2 and other genes (e.g., IDO1, TGFβ, and MMP9) observed in diffuse GC, but not intestinal GC (Sup Table 3 and Table 4), suggests a role of tumor and immune cells that merits further consideration using a larger sample of patients. The gene discussed is TDO2; the disease is gastric cancer.